Risk factors for blood loss during sacral tumor resection.
Extensive hemorrhage is a serious complication during sacral tumor resection. Identifying the risk factors predicting the possibility of extensive hemorrhage would be important to predict which patients would need large amounts of transfused blood intraoperatively and postoperatively and which patients would need blood control by vascular occlusion. We retrospectively reviewed 173 patients who underwent sacral tumor resection performed at our institute between 2003 and 2007. Patients with an estimated total blood loss greater than 3000 mL were classified as having a large amount of blood loss. Sixty-nine (39.88%) patients had blood loss greater than 3000 mL. Male gender, excessive tumor blood supply, tumors involving the S2 body and cephalad to the S2 body, tumor volume greater than 200 cm(3), aorta occlusion, surgical approach, reconstruction, and operative time were associated with a large amount of blood loss. Tumors cephalad to the S2-S3 disc space (odds ratio, 3.840), tumor volume greater than 200 cm(3) (odds ratio, 3.381), and excessive blood supply (odds ratio, 2.281) independently predicted a large amount of blood loss. Sacral tumors that invaded cephalad to the S2-S3 disc space with a volume greater than 200 cm(3) and an excessive blood supply were likely to have a large amount of blood loss during resection.


METHODS
Level III, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.
Tang
Xiaodong
X
Musculoskeletal Tumor Center, People's Hospital, Peking University, Beijing, 100044, China.
Guo
Wei
W
Yang
Rongli
R
Tang
Shun
S
Ji
Tao
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D016063:Blood Loss, Surgical; D002648:Child; D005260:Female; D006470:Hemorrhage / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D012307:Risk Factors; D012447:Sacrum / Q000098:blood supply / Q000601:surgery*; D013125:Spinal Neoplasms / Q000098:blood supply / Q000601:surgery*; D016896:Treatment Outcome
J Bone Joint Surg Am. 2001 Nov;83(11):1674-81
11701790
J Surg Oncol. 2001 Apr;76(4):301-7
11320524
Clin Orthop Relat Res. 2005 Jun;(435):211-8
15930941
J Bone Joint Surg Am. 2005 Oct;87(10):2211-6
16203885
Cancer. 2000 May 1;88(9):2122-34
10813725
Skeletal Radiol. 1992;21(8):523-7
1465646
J Surg Oncol. 2006 Sep 1;94(3):203-11
16900511
Clin Orthop Relat Res. 2005 Sep;438:42-50
16131868
Am Surg. 2000 Jan;66(1):61-5
10651350
Spine (Phila Pa 1976). 2003 Aug 1;28(15):E296-301
12897508
Semin Oncol. 2001 Dec;28(6):560-4
11740809
J Neurosurg Spine. 2005 Aug;3(2):111-22
16370300
Clin Orthop Relat Res. 2006 Sep;450:82-8
16906087
Spine (Phila Pa 1976). 2005 Oct 15;30(20):E614-6
16227879
Clin Orthop Relat Res. 1987 Feb;(215):91-8
3542333
J Orthop Sci. 2000;5(4):321-7
10982678
Clin Orthop Relat Res. 2006 Mar;444:209-15
16523141
Clin Orthop Relat Res. 2000 Dec;(381):192-203
11127656
Arch Orthop Trauma Surg. 2002 Apr;122(3):148-55
11927996
Anesth Analg. 2007 Sep;105(3):700-3
17717226
J Vasc Interv Radiol. 1996 Jan-Feb;7(1):81-8
8773979
J Surg Oncol. 2006 Mar 15;93(4):312-7
16496365
Instr Course Lect. 1999;48:655-65
10098095
Arch Orthop Trauma Surg. 2003 Jun;123(5):247-51
12692673
Neurosurgery. 1990 Nov;27(5):755-9
2259405
Clin Orthop Relat Res. 1993 Jun;(291):215-21
8504603